Chemokines as effector and target molecules in vascular biology.
暂无分享,去创建一个
[1] R. Solari,et al. "Chemokine receptors as therapeutic targets: Why aren't there more drugs?". , 2015, European journal of pharmacology.
[2] S. Sozzani,et al. Chemokines as relay signals in human dendritic cell migration: Serum amyloid A kicks off chemotaxis , 2015, European journal of immunology.
[3] M. Smit,et al. Cutting Edge: GPR35/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17 , 2015, The Journal of Immunology.
[4] S. Schulz,et al. CXCL14 is no direct modulator of CXCR4 , 2014, FEBS letters.
[5] R. Gamelli,et al. Chemokine (C-X-C Motif) Receptor 4 and Atypical Chemokine Receptor 3 Regulate Vascular α1-Adrenergic Receptor Function , 2014, Molecular medicine.
[6] C. Parent,et al. New paradigms in the establishment and maintenance of gradients during directed cell migration. , 2014, Current opinion in cell biology.
[7] Samantha L. Hoopes,et al. Decoy receptor CXCR7 modulates adrenomedullin-mediated cardiac and lymphatic vascular development. , 2014, Developmental cell.
[8] J. Shelhamer,et al. The fish oil ingredient, docosahexaenoic acid, activates cytosolic phospholipase A2 via GPR120 receptor to produce prostaglandin E2 and plays an anti‐inflammatory role in macrophages , 2014, Immunology.
[9] S. Sozzani,et al. LXR‐dependent and ‐independent effects of oxysterols on immunity and tumor growth , 2014, European journal of immunology.
[10] P. Hevezi,et al. CXCL17 Is a Major Chemotactic Factor for Lung Macrophages , 2014, The Journal of Immunology.
[11] C. Mackay,et al. Diet, metabolites, and "western-lifestyle" inflammatory diseases. , 2014, Immunity.
[12] C. Weber,et al. The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease , 2014, Front. Physiol..
[13] A. IJzerman,et al. Bias in chemokine receptor signalling. , 2014, Trends in immunology.
[14] T. Hara,et al. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis , 2014, Biomolecular concepts.
[15] A. Luster,et al. Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.
[16] M. V. van Zandvoort,et al. Activation of CXCR7 Limits Atherosclerosis and Improves Hyperlipidemia by Increasing Cholesterol Uptake in Adipose Tissue , 2014, Circulation.
[17] S. Sozzani,et al. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells. , 2014, Immunobiology.
[18] J. Tao,et al. CXCR7 Upregulation Is Required for Early Endothelial Progenitor Cell–Mediated Endothelial Repair in Patients With Hypertension , 2014, Hypertension.
[19] A. Mantovani,et al. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.
[20] S. Sozzani,et al. Angiogenic and antiangiogenic chemokines. , 2014, Chemical immunology and allergy.
[21] Q. Wu,et al. Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma , 2013, Oncogene.
[22] S. Rajagopal,et al. Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors* , 2013, The Journal of Biological Chemistry.
[23] R. Nibbs,et al. Immune regulation by atypical chemokine receptors , 2013, Nature Reviews Immunology.
[24] A. Dart,et al. Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells , 2013, PloS one.
[25] P. Tewary,et al. Alarmin‐induced cell migration , 2013, European journal of immunology.
[26] A. Mantovani,et al. β-Arrestin–Dependent Activation of the Cofilin Pathway Is Required for the Scavenging Activity of the Atypical Chemokine Receptor D6 , 2013, Science Signaling.
[27] J. Gustafsson,et al. The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils , 2013, The Journal of experimental medicine.
[28] D. Guo,et al. Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7* , 2013, The Journal of Biological Chemistry.
[29] E. Borroni,et al. Atypical chemokine receptors: from silence to sound. , 2013, Biochemical Society transactions.
[30] R. Leurs,et al. β-Arrestin Recruitment and G Protein Signaling by the Atypical Human Chemokine Decoy Receptor CCX-CKR* , 2013, The Journal of Biological Chemistry.
[31] C. Luo,et al. CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor. , 2013, American journal of physiology. Endocrinology and metabolism.
[32] A. Richmond,et al. The Chemokine Receptors CXCR1 and CXCR2 Couple to Distinct G Protein-Coupled Receptor Kinases To Mediate and Regulate Leukocyte Functions , 2012, The Journal of Immunology.
[33] B. Lévy,et al. The Chemokine Decoy Receptor D6 Prevents Excessive Inflammation and Adverse Ventricular Remodeling After Myocardial Infarction , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[34] A. Mantovani,et al. The biochemistry and biology of the atypical chemokine receptors. , 2012, Immunology letters.
[35] J. Van Damme,et al. Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response. , 2012, Immunology letters.
[36] P. Proost,et al. Overview of the mechanisms regulating chemokine activity and availability. , 2012, Immunology letters.
[37] C. Martínez-A,et al. Chemokine receptor oligomerization: a further step toward chemokine function. , 2012, Immunology letters.
[38] H. Toh,et al. Evolutionary Analysis of Functional Divergence among Chemokine Receptors, Decoy Receptors, and Viral Receptors , 2012, Front. Microbio..
[39] M. Selman,et al. CXCL17 Is a Mucosal Chemokine Elevated in Idiopathic Pulmonary Fibrosis That Exhibits Broad Antimicrobial Activity , 2012, The Journal of Immunology.
[40] U. V. von Andrian,et al. Chemokine Guidance of Central Memory T Cells Is Critical for Antiviral Recall Responses in Lymph Nodes , 2012, Cell.
[41] L. Varani,et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 , 2012, The Journal of experimental medicine.
[42] A. Magiera,et al. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation. , 2012, Blood.
[43] Michael H. Preuss,et al. RANTES/CCL5 and Risk for Coronary Events: Results from the MONICA/KORA Augsburg Case-Cohort, Athero-Express and CARDIoGRAM Studies , 2011, PloS one.
[44] M. Febbraio,et al. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. , 2011, Journal of molecular and cellular cardiology.
[45] T. Schall,et al. Overcoming hurdles in developing successful drugs targeting chemokine receptors , 2011, Nature Reviews Immunology.
[46] Borna Mehrad,et al. Chemokines as mediators of tumor angiogenesis and neovascularization. , 2011, Experimental cell research.
[47] P. Proost,et al. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. , 2011, Experimental cell research.
[48] J. Van Damme,et al. The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer. , 2011, Cytokine & growth factor reviews.
[49] A. Luster,et al. CXCR3 ligands: redundant, collaborative and antagonistic functions , 2011, Immunology and cell biology.
[50] M. Parmentier,et al. Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. , 2011, Blood.
[51] M. Hristov,et al. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment , 2010, Journal of cellular and molecular medicine.
[52] Silvano Sozzani,et al. Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.
[53] S. Sozzani,et al. Trafficking properties of plasmacytoid dendritic cells in health and disease. , 2010, Trends in immunology.
[54] B. Adams. Faculty Opinions recommendation of Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. , 2010 .
[55] T. Akasaka,et al. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[56] A. Mantovani,et al. Chemokine decoy receptors: structure-function and biological properties. , 2010, Current topics in microbiology and immunology.
[57] R. Strieter,et al. CXC chemokines in cancer angiogenesis and metastases. , 2010, Advances in cancer research.
[58] R. Lefkowitz,et al. β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7 , 2009, Proceedings of the National Academy of Sciences.
[59] M. Parmentier,et al. Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists* , 2009, The Journal of Biological Chemistry.
[60] Robert J. Lefkowitz,et al. Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands , 2009, Proceedings of the National Academy of Sciences.
[61] F. Baleux,et al. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. , 2009, Blood.
[62] F. Moll,et al. Carotid Atherosclerotic Plaques Stabilize After Stroke: Insights Into the Natural Process of Atherosclerotic Plaque Stabilization , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[63] Athena,et al. G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation , 2009 .
[64] T. Handel,et al. Modulation of chemokine receptor activity through dimerization and crosstalk , 2009, Cellular and Molecular Life Sciences.
[65] M. Parmentier,et al. Synergy between Coproduced CC and CXC Chemokines in Monocyte Chemotaxis through Receptor-Mediated Events , 2008, Molecular Pharmacology.
[66] Tullio Pozzan,et al. CXCR4–CCR5: A couple modulating T cell functions , 2008, Proceedings of the National Academy of Sciences.
[67] T. Simon,et al. Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice , 2008, Circulation.
[68] Erez Raz,et al. Control of Chemokine-Guided Cell Migration by Ligand Sequestration , 2008, Cell.
[69] Johan Kuiper,et al. CXCR3 Antagonist NBI-74330 Attenuates Atherosclerotic Plaque Formation in LDL Receptor–Deficient Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[70] H. Sarau,et al. CXCR2 Blockade Impairs Angiotensin II–Induced CC Chemokine Synthesis and Mononuclear Leukocyte Infiltration , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[71] H. Putter,et al. CC Chemokine Ligand-5 (CCL5/RANTES) and CC Chemokine Ligand-18 (CCL18/PARC) Are Specific Markers of Refractory Unstable Angina Pectoris and Are Transiently Raised During Severe Ischemic Symptoms , 2007, Circulation.
[72] Richard P. Harvey,et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 , 2007, Proceedings of the National Academy of Sciences.
[73] N. Frangogiannis. Chemokines in ischemia and reperfusion , 2007, Thrombosis and Haemostasis.
[74] Patrick W Serruys,et al. Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. , 2007, The Journal of clinical investigation.
[75] B. Haribabu,et al. Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. , 2007, Blood.
[76] F. Tacke,et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. , 2007, The Journal of clinical investigation.
[77] Kevin Wei,et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development , 2006, The Journal of experimental medicine.
[78] A. Tedgui,et al. Role of Bone Marrow–Derived CC-Chemokine Receptor 5 in the Development of Atherosclerosis of Low-Density Lipoprotein Receptor Knockout Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[79] M. Baba,et al. Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent Anti-HIV-1 activity. , 2006, Journal of medicinal chemistry.
[80] Eric Reiter,et al. GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling , 2006, Trends in Endocrinology & Metabolism.
[81] R. Terkeltaub,et al. Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. , 2006, The American journal of pathology.
[82] G. Frantz,et al. Cutting Edge: Novel Human Dendritic Cell- and Monocyte-Attracting Chemokine-Like Protein Identified by Fold Recognition Methods , 2006, The Journal of Immunology.
[83] R. Schuster,et al. The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[84] A. Mantovani,et al. Migration of dendritic cells across blood and lymphatic endothelial barriers , 2005, Thrombosis and Haemostasis.
[85] Eric Reiter,et al. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. , 2006, Trends in endocrinology and metabolism: TEM.
[86] H. Fujiwara,et al. HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[87] C. Mackay,et al. Gene Profiling in Atherosclerosis Reveals a Key Role for Small Inducible Cytokines: Validation Using a Novel Monocyte Chemoattractant Protein Monoclonal Antibody , 2005, Circulation.
[88] Silvano Sozzani,et al. The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.
[89] A. El‐Naggar,et al. BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells , 2004, Cancer Research.
[90] I. Charo,et al. Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.
[91] B. Haribabu. Leukotrienes: Novel targets for vascular disease. , 2004, Discover medicine.
[92] W. März,et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. , 2004, European heart journal.
[93] D. Greaves,et al. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics , 2004, Current opinion in lipidology.
[94] U. V. von Andrian,et al. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.
[95] H. Baba,et al. Cloning of a G‐protein‐coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells , 2004, Cancer science.
[96] D. Greaves,et al. Smooth Muscle Cells in Human Atherosclerotic Plaques Express the Fractalkine Receptor CX3CR1 and Undergo Chemotaxis to the CX3C Chemokine Fractalkine (CX3CL1) , 2003, Circulation.
[97] D. Ribatti,et al. Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis1 , 2003, The Journal of Immunology.
[98] M. Parmentier,et al. Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation* , 2003, Journal of Biological Chemistry.
[99] Steffen Jung,et al. Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.
[100] R. D'Agostino,et al. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. , 2003, The Journal of clinical investigation.
[101] Ravindra Uppaluri,et al. Cutting Edge: IFN-Producing Cells Respond to CXCR3 Ligands in the Presence of CXCL12 and Secrete Inflammatory Chemokines upon Activation1 , 2002, The Journal of Immunology.
[102] R. Ransohoff,et al. The Chemokine Receptor CXCR2 Controls Positioning of Oligodendrocyte Precursors in Developing Spinal Cord by Arresting Their Migration , 2002, Cell.
[103] S. Frøland,et al. Stromal Cell–Derived Factor-1&agr; in Unstable Angina: Potential Antiinflammatory and Matrix-Stabilizing Effects , 2002, Circulation.
[104] R. Strieter,et al. Potential role for Duffy antigen chemokine‐binding protein in angiogenesis and maintenance of homeostasis in response to stress , 2002, Journal of leukocyte biology.
[105] S. Frøland,et al. Chemokines in myocardial failure – pathogenic importance and potential therapeutic targets , 2001, Clinical and experimental immunology.
[106] P. Allavena,et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys , 2000, Nature Immunology.
[107] A. Richmond,et al. Delayed wound healing in CXCR2 knockout mice. , 2000, The Journal of investigative dermatology.
[108] G. McFadden,et al. The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. , 2000, The Journal of clinical investigation.
[109] P. Allavena,et al. Hepatocyte Growth Factor (HGF) Stimulates Tumor Cells to Release Chemokines Active in Recruiting Dendritic Cells , 2000 .
[110] A. Mantovani,et al. The chemokine system: redundancy for robust outputs. , 1999, Immunology today.
[111] P. Allavena,et al. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. , 1998, Blood.
[112] I. Charo,et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.
[113] R Bonecchi,et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. , 1998, Journal of immunology.
[114] Kouji Matsushima,et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.
[115] A. Mantovani,et al. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. , 1994, Journal of immunology.
[116] W. Wood,et al. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. , 1994, Science.
[117] A. Rot. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. , 1992, Immunology today.
[118] A. Fogelman,et al. Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.